Jakob R. Passweg

发表

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

H. Einsele, G. Dini, A. Velardi, 2010, Bone Marrow Transplantation.

Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT

A. Gratwohl, A. Buser, J. Passweg, 2011, Bone Marrow Transplantation.

IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE

J. Klein, A. Gratwohl, M. Horowitz, 1997, British journal of haematology.

Tumors that look for their springtime in APRIL.

J. Passweg, T. Matthes, P. Dietrich, 2009, Critical reviews in oncology/hematology.

Clostridium difficile infection is associated with graft loss in solid organ transplant recipients

F. Ruschitzka, C. Lovis, N. Mueller, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Haematopoietic stem cell transplantation for refractory autoimmune cytopenia

A. Wåhlin, P. Veys, A. Gratwohl, 2004 .

Solid cancers after bone marrow transplantation.

R. Hoover, H. Deeg, W. Travis, 1997, The New England journal of medicine.

Bone marrow transplantation--1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry.

J. Armitage, M. Horowitz, R. Gale, 1994, Journal of hematotherapy.

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

J. Klein, A. Barrett, M. Horowitz, 1998, Bone Marrow Transplantation.

Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

J. V. Stone, J. Klein, J. Wingard, 1999 .

Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio

E. Vellenga, F. Baron, G. Meloni, 2016, Leukemia.

Quality of life and social integration after allogeneic hematopoietic SCT

R. Miralbell, J. Passweg, B. Chapuis, 2008, Bone Marrow Transplantation.

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

A. Gennery, N. Kröger, A. Nagler, 2016, Bone Marrow Transplantation.

Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.

E. Vellenga, A. Gratwohl, J. Passweg, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study

F. Ruschitzka, C. Lovis, N. Mueller, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

J. Gribben, L. Bullinger, P. Sonneveld, 2022, ESMO Open.

Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling?

A. Tichelli, Jakob R. Passweg, 2009, Haematologica.

University of Birmingham Allogeneic stem cell transplantation benefits for patients 60 years with acute myeloid leukemia and FLT3 internal tandem duplication:

J. Esteve, M. Labopin, P. Chevallier, 2018 .

Numerical impairment of nestin+ bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML

A. Buser, J. Passweg, A. Tzankov, 2015, Bone Marrow Transplantation.

Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission

M. Tanimoto, M. Tomonaga, R. Ohno, 1998, Bone Marrow Transplantation.

Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group.

H. Heimpel, J. Hasford, M. Horowitz, 1998, Blood.

Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes

A. Buser, S. Meyer, M. Medinger, 2023, Frontiers in oncology.

Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.

E. Vellenga, T. Pabst, G. Ossenkoppele, 2012, Journal of Clinical Oncology.

Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia

A. Gratwohl, P. Ljungman, K. Sobocinski, 1998, Bone Marrow Transplantation.

Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study

J. Bourhis, M. Mohty, U. Salmenniemi, 2023, Bone Marrow Transplantation.

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.

J. Fay, H. Deeg, J. Tolar, 2011, Blood.

HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.

H. Deeg, B. George, J. Passweg, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.